ESC 365 - Sacubitril/valsartan and SGLT2 inhibitors as novel treatment strategies

HFA Premium Access

Sacubitril/valsartan and SGLT2 inhibitors as novel treatment strategies

Session: Solving the puzzle of HFpEF: pearls for clinical management

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor M. Metra (Brescia, IT)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Marco Metra

University of Brescia, Brescia (Italy)

139 presentations

38 followers

4 more presentations in this session

New insights into the multifaceted mechanisms and clinical implications.

Speaker: Professor B. Pieske (Rostock, DE)

The spectrum of phenotypes: diagnostic, therapeutic, and prognostic relevance.

Speaker: Doctor M. Senni (Bergamo, IT)

The conundrum of comorbidities and their role in management.

Speaker: Professor G. Savarese (Stockholm, SE)

Solving the puzzle of HFpEF: pearls for clinical management - discussion.

Access the full session

Solving the puzzle of HFpEF: pearls for clinical management

Speakers: Professor M. Metra, Professor B. Pieske, Doctor M. Senni, Professor G. Savarese

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources